US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Regeneron Pharmaceuticals

552.38

+3.100.56%

Volume:160.64K

Turnover:88.54M

Market Cap:59.12B

PE:14.41

High:556.46

Open:548.07

Low:545.00

Close:549.28

Loading ...

Overview Company News Filings

Apogee Therapeutics' Investigational Atopic Dermatitis Potential Shows Strong Tolerability, Extended Half-Life in Early Trial

Regeneron Says Linvoseltamab Recommended for EU Approval to Treat Multiple Myeloma

MT Newswires Live

Regeneron Gets CHMP Backing of Linvoseltamab in Multiple Myeloma

Linvoseltamab Recommended for EU Approval by the Chmp to Treat Relapsed/Refractory Multiple Myeloma

THOMSON REUTERS

Regeneron Pharmaceuticals Inc - European Commission Final Decision Expected in Coming Months

THOMSON REUTERS

Linvoseltamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Multiple Myeloma

BUZZ-Intellia Therapeutics jumps on better-than-expected Q4 collaboration revenue

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day

Regeneron Says US FDA Accepts for Review Resubmission of Application for Follicular Lymphoma Drug

MT Newswires Live

Regeneron: FDA Accepts Odronextamab Lymphoma Drug Resubmission

Odronextamab Bla Accepted for FDA Review for the Treatment of Relapsed/Refractory Follicular Lymphoma

THOMSON REUTERS

Regeneron Pharmaceuticals Inc - FDA Decision on Odronextamab Expected by July 30, 2025

THOMSON REUTERS

Odronextamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Follicular Lymphoma

Regeneron Pharmaceuticals, Inc. (REGN): Among the Stocks That Will Go to The Moon According to Analysts

Regeneron Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

Regeneron announces updated DB-OTO data from CHORD trial

BRIEF-Regeneron's DB-OTO Results Show Hearing Improvements In Children With Profound Genetic Hearing Loss

Regeneron's gene therapy study shows improved hearing in children with congenital deafness

Regeneron: 72-Week Results for Db-Oto Shows Speech and Development Progress in First Child Dosed at 10 Months of Age

THOMSON REUTERS

Regeneron: 10 of 11 Children With at Least One Post-Treatment Assessment Showed Notable Improvements in Hearing in Phase 1/2 Chord Trial

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/REGN/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"REGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REGN\",,,,,undefined,":{"symbol":"REGN","market":"US","secType":"STK","nameCN":"Regeneron Pharmaceuticals","latestPrice":552.38,"timestamp":1744901046925,"preClose":549.28,"halted":0,"volume":160635,"delay":0,"floatShares":102995909,"shares":107024682,"eps":38.34,"marketStatus":"Trading","change":3.1,"latestTime":"04-17 10:44:14 EDT","open":548.07,"high":556.4564,"low":545.0001,"amount":88540445.80875,"amplitude":0.020857,"askPrice":553.33,"askSize":21,"bidPrice":552.4,"bidSize":3,"shortable":3,"etf":0,"ttmEps":38.34,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1744920000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":549.28,"preHourTrading":{"tag":"盘前","latestPrice":549.8,"preClose":549.28,"latestTime":"09:25 EDT","volume":1237,"amount":679660.9044100001,"timestamp":1744896300038},"postHourTrading":{"tag":"盘后","latestPrice":549.28,"preClose":549.28,"latestTime":"19:57 EDT","volume":34583,"amount":18995785.65,"timestamp":1744847851842},"volumeRatio":0.804775,"impliedVol":0.5127,"impliedVolPercentile":0.9641},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REGN\",,,,,undefined,":{"symbol":"REGN","floatShares":102995909,"roa":"7.31%","roe":"15.95%","lyrEps":40.895273,"volumeRatio":0.804775,"shares":107024682,"dividePrice":3.52,"high":556.4564,"amplitude":0.020857,"preClose":549.28,"low":545.0001,"week52Low":525.99,"pbRate":"2.01","psRate":"4.16","week52High":1211.2,"institutionHeld":0.8855,"latestPrice":552.38,"committee":-0.75,"eps":38.34,"divideRate":0.006372,"volume":160635,"delay":0,"ttmEps":38.34,"open":548.07,"prevYearClose":712.33,"prevWeekClose":554.18,"prevMonthClose":634.23,"prevQuarterClose":634.23,"fiveDayClose":546.39,"twentyDayClose":662.62,"sixtyDayClose":680.03,"earningDate":1745856000000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"REGN\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516752656","title":"Apogee Therapeutics' Investigational Atopic Dermatitis Potential Shows Strong Tolerability, Extended Half-Life in Early Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2516752656","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516752656?lang=en_us&edition=fundamental","pubTime":"2025-03-04 01:16","pubTimestamp":1741022203,"startTime":"0","endTime":"0","summary":"On Monday, Apogee Therapeutics, Inc.  released interim Phase 1 results from its first-in-human trial of APG990.APG990 interim Phase 1 pharmacokinetic  data showed a half-life of approximately 60 days across doses tested.Key data from the 40-healthy subject trial showed:. APG990 demonstrated a potential best-in-class PK profile, including a half-life of approximately 60 days, supporting the potential for every three- and six-month maintenance dosing. The PK profile supports the potential for a single 2 mL co-formulated injection of APG279  administered every three and six months.APG990 was well tolerated across all five cohorts, with doses up to 1,200mg. The most common  treatment-emergent adverse events  were headache.53% of participants observed at least one TEAE.In addition, preclinical studies of the combination of APG777 and APG990 showed potential for enhanced pharmacologic responses relative to individual agents and exhibited no safety findings at any dose level, including the hi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/apogee-therapeutics-investigational-atopic-dermatitis-171643556.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0058720904.USD","NVIW.SI","LU2023250504.SGD","LU2089984988.USD","LU2362541513.USD","TQQQ","LU2237438978.USD","BK4139","LU0114720955.EUR","SNY","BK4007","BK4588","APGE","QLD","LU0320765992.SGD","REGN","PK","QID","BK4585","LU2362540622.SGD","LU0823416689.USD","LU0109394709.USD","SQQQ","LU2362541273.HKD","USAW.SI","USJW.SI","PSQ","BK4181","TSYW.SI","BK4218","LU0289739699.SGD","IE00BFXG1179.USD","LU0882574055.USD","LU1917777945.USD","NQmain","LU2468319806.SGD",".IXIC","LU1974910355.USD","LU0889565916.HKD","MNQmain","LU0053666078.USD","LU2106854487.HKD"],"gpt_icon":1},{"id":"2514265893","title":"Regeneron Says Linvoseltamab Recommended for EU Approval to Treat Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2514265893","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514265893?lang=en_us&edition=fundamental","pubTime":"2025-02-28 20:40","pubTimestamp":1740746435,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals  said Friday that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended a conditional marketing authorization for linvoseltamab to treat adults with relapsed and refractory multiple myeloma.The company said the recommendation specifically covers patients who have received at least three prior therapies.The committee's positive opinion was based on data from a phase 1/2 trial investigating linvoseltamab in 282 patients, Regeneron said.The European Commission is expected to issue a final decision in the coming months, the company said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2237438978.USD","LU2089984988.USD","LU2362541273.HKD","LU0053666078.USD","BK4139","BK4588","LU0320765992.SGD","LU0058720904.USD","LU1917777945.USD","LU2362540622.SGD","LU2468319806.SGD","BK4585","LU0114720955.EUR","LU0109394709.USD","BK4156","LU1974910355.USD","LU2023250504.SGD","LU2362541513.USD","LU0889565916.HKD","LU0289739699.SGD","LU0882574055.USD","LU2106854487.HKD","LU0823416689.USD","REGN"],"gpt_icon":0},{"id":"2514326082","title":"Regeneron Gets CHMP Backing of Linvoseltamab in Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2514326082","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514326082?lang=en_us&edition=fundamental","pubTime":"2025-02-28 20:34","pubTimestamp":1740746040,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals said the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended conditional marketing approval of linvoseltamab for certain adults with the blood cancer multiple myeloma.Regeneron on Friday said the recommendation covers adults with adults with relapsed and refractory multiple myeloma who have received at least three prior therapies, including a proteasome inhibitor, an immunomodulatory agent and an anti-CD38 monoclonal antibody, and have shown disease progression on the last therapy.The Tarrytown, N.Y., biotechnology company said the European Commission, which generally follows the CHMP's advice, is expected to announce a final decision in the coming months.The U.S. Food and Drug Administration earlier this month accepted Regeneron's resubmitted application seeking approval of linvoseltamab and set a target action date of July 10 for a decision.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2106854487.HKD","BK4585","LU0889565916.HKD","LU2089984988.USD","LU0823416689.USD","LU0882574055.USD","LU2362541273.HKD","LU1974910355.USD","LU2023250504.SGD","BK4139","LU2362540622.SGD","CHMP","REGN","LU0109394709.USD","LU2237438978.USD","LU2362541513.USD","LU0114720955.EUR","LU0053666078.USD","LU1917777945.USD","LU0058720904.USD","LU2468319806.SGD","BK4087","LU0289739699.SGD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2514340323","title":"Linvoseltamab Recommended for EU Approval by the Chmp to Treat Relapsed/Refractory Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2514340323","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514340323?lang=en_us&edition=fundamental","pubTime":"2025-02-28 20:00","pubTimestamp":1740744002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nTUA9DHM4J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0882574055.USD","LU0114720955.EUR","LU0058720904.USD","LU1974910355.USD","REGN","LU0109394709.USD","LU0289739699.SGD","BK4588","LU2106854487.HKD","LU2468319806.SGD","LU0320765992.SGD","BK4585","LU0053666078.USD","LU2362541513.USD","LU0889565916.HKD","LU2237438978.USD","BK4139","LU2362541273.HKD","LU0823416689.USD","LU2023250504.SGD","LU2089984988.USD","LU1917777945.USD","LU2362540622.SGD"],"gpt_icon":0},{"id":"2514323305","title":"Regeneron Pharmaceuticals Inc - European Commission Final Decision Expected in Coming Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2514323305","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514323305?lang=en_us&edition=fundamental","pubTime":"2025-02-28 20:00","pubTimestamp":1740744002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nTUA9DHM4J:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LU2362540622.SGD","LU0320765992.SGD","LU1974910355.USD","LU2362541273.HKD","LU0058720904.USD","LU0823416689.USD","LU2468319806.SGD","LU0109394709.USD","LU2089984988.USD","LU0289739699.SGD","BK4585","LU2362541513.USD","LU0889565916.HKD","LU0882574055.USD","LU2023250504.SGD","LU1917777945.USD","LU2106854487.HKD","LU0053666078.USD","LU2237438978.USD","REGN","BK4588","LU0114720955.EUR"],"gpt_icon":0},{"id":"2514960323","title":"Linvoseltamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2514960323","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514960323?lang=en_us&edition=fundamental","pubTime":"2025-02-28 20:00","pubTimestamp":1740744000,"startTime":"0","endTime":"0","summary":"TARRYTOWN, N.Y., Feb. 28, 2025  -- Regeneron Pharmaceuticals, Inc.  today announced that the European Medicines Agency’s  Committee for Medicinal Products for Human Use  has adopted a positive opinion recommending conditional marketing authorization of linvoseltamab to treat adults with relapsed and refractory (R/R) multiple myeloma . The recommendation is specific to those who have received at least three prior therapies, including a proteasome inhibitor, an immunomodulatory agent and an anti-CD38 monoclonal antibody, and have demonstrated disease progression on the last therapy. The European Commission is expected to announce a final decision in the coming months.Linvoseltamab is investigational and has not been approved by any regulatory authority.Eligibility in the Phase 2 portion requires patients to have received at least three prior lines of therapy or have triple-class refractory MM. Linvoseltamab is administered with an initial step-up dosing regimen followed by the full 200 m","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/linvoseltamab-recommended-eu-approval-chmp-120000259.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","LU0109394709.USD","BK4156","REGN","LU0053666078.USD","LU0114720955.EUR","LU2362540622.SGD","BK4087","LU0058720904.USD","BK4585","LU0889565916.HKD","LU0882574055.USD","LU2468319806.SGD","LU0823416689.USD","CHMP","LU2237438978.USD","LU1974910355.USD","LU2023250504.SGD","LU0289739699.SGD","LU1917777945.USD","BK4588","LU0320765992.SGD","LU2106854487.HKD","LU2089984988.USD","EU","LU2362541273.HKD","LU2362541513.USD"],"gpt_icon":0},{"id":"2514438741","title":"BUZZ-Intellia Therapeutics jumps on better-than-expected Q4 collaboration revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2514438741","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514438741?lang=en_us&edition=fundamental","pubTime":"2025-02-28 00:42","pubTimestamp":1740674569,"startTime":"0","endTime":"0","summary":"BUZZ-Intellia Therapeutics jumps on better-than-expected Q4 collaboration revenue** Shares of Massachusetts-based gene-editing firm Intellia Therapeutics NTLA.O up 8.4% at $11.71** Company posts Q4 collaboration revenue of $12.9 million, beating analysts' estimates of $8.5 million, according to data compiled by LSEG ** Company's sales was mainly driven by collaboration revenue received under the Regeneron REGN.O agreements to develop gene-editing therapies for neurological and muscular disease. ** Brokerage Leerink Partners expects shares to rise in the mid-single digits as company fleshed out details including operating expenses on call; NTLA expects 5%-10% lower operating expenses vs a year ago","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nL3N3PI1Q7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN","SIVBQ","NTLA"],"gpt_icon":0},{"id":"2514932078","title":"Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2514932078","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514932078?lang=en_us&edition=fundamental","pubTime":"2025-02-27 05:41","pubTimestamp":1740606060,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Regeneron Pharmaceuticals Inc.  shed 2.28% to $706.94 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index  rising 0.01% to 5,956.06 and the Dow Jones Industrial Average  falling 0.43% to 43,433.12.The stock's fall snapped a six-day winning streak.Regeneron Pharmaceuticals Inc. closed 41.63% below its 52-week high of $1,211.20, which the company achieved on August 27th.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Amgen Inc.  fell 2.93% to $306.38, Moderna Inc.  rose 0.90% to $33.58, and Gilead Sciences Inc.  fell 0.96% to $110.46.Trading volume  remained 191,281 below its 50-day average volume of 904,094.Data source: Dow Jones Market Data, FactSet. Data compiled February 26, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch i","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN"],"gpt_icon":0},{"id":"2514485866","title":"Regeneron Says US FDA Accepts for Review Resubmission of Application for Follicular Lymphoma Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2514485866","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514485866?lang=en_us&edition=fundamental","pubTime":"2025-02-26 21:48","pubTimestamp":1740577725,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals (REGN) said Wednesday that the US Food and Drug Administration has accepted for review the resubmission of its biologics license application for odronextamab drug, a treatmen","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","LU2362540622.SGD","LU0114720955.EUR","LU0823416689.USD","LU2237438978.USD","LU0053666078.USD","LU2089984988.USD","LU0109394709.USD","LU2023250504.SGD","LU0882574055.USD","LU2362541513.USD","LU1917777945.USD","LU1974910355.USD","REGN","BK4588","BK4585","LU2468319806.SGD","LU0889565916.HKD","LU0058720904.USD","LU0289739699.SGD","LU2362541273.HKD","LU2106854487.HKD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2514832390","title":"Regeneron: FDA Accepts Odronextamab Lymphoma Drug Resubmission","url":"https://stock-news.laohu8.com/highlight/detail?id=2514832390","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514832390?lang=en_us&edition=fundamental","pubTime":"2025-02-26 20:43","pubTimestamp":1740573780,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals said the Food and Drug Administration has accepted for review its resubmitted application seeking approval of odronextamab for certain patients with one of the most-common subtypes of non-Hodgkin lymphoma.The FDA last year turned away Regeneron's initial odronextamab application due to issues related to the enrollment status of confirmatory trials.The Tarrytown, N.Y., biotechnology company on Wednesday said the FDA's acceptance of its resubmission follows the achievement of an FDA-mandated enrollment target.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Regeneron: FDA Accepts Odronextamab Lymphoma Drug Resubmission","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU2362540622.SGD","LU0114720955.EUR","LU0823416689.USD","LU2237438978.USD","LU0053666078.USD","LU2089984988.USD","LU0109394709.USD","LU2023250504.SGD","LU0882574055.USD","LU2362541513.USD","LU1917777945.USD","LU1974910355.USD","REGN","BK4588","BK4585","LU2468319806.SGD","LU0889565916.HKD","LU0058720904.USD","LU0289739699.SGD","LU2362541273.HKD","LU2106854487.HKD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2514839379","title":"Odronextamab Bla Accepted for FDA Review for the Treatment of Relapsed/Refractory Follicular Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2514839379","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514839379?lang=en_us&edition=fundamental","pubTime":"2025-02-26 20:00","pubTimestamp":1740571219,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nTUA9Y9YNZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0882574055.USD","LU0109394709.USD","LU2362540622.SGD","LU1974910355.USD","LU2237438978.USD","LU1917777945.USD","LU0114720955.EUR","BK4585","BK4139","LU2468319806.SGD","REGN","LU0058720904.USD","BK4588","LU0289739699.SGD","LU2089984988.USD","LU0053666078.USD","LU0320765992.SGD","LU2362541273.HKD","LU2106854487.HKD","LU2362541513.USD","LU0823416689.USD","LU0889565916.HKD","LU2023250504.SGD"],"gpt_icon":0},{"id":"2514313778","title":"Regeneron Pharmaceuticals Inc - FDA Decision on Odronextamab Expected by July 30, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2514313778","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514313778?lang=en_us&edition=fundamental","pubTime":"2025-02-26 20:00","pubTimestamp":1740571219,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nTUA9Y9YNZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0882574055.USD","LU0109394709.USD","LU2362540622.SGD","LU1974910355.USD","LU2237438978.USD","LU1917777945.USD","LU0114720955.EUR","BK4585","BK4139","LU2468319806.SGD","REGN","LU0058720904.USD","BK4588","LU0289739699.SGD","LU2089984988.USD","LU0053666078.USD","LU0320765992.SGD","LU2362541273.HKD","LU2106854487.HKD","LU2362541513.USD","LU0823416689.USD","LU0889565916.HKD","LU2023250504.SGD"],"gpt_icon":0},{"id":"2514083912","title":"Odronextamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Follicular Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2514083912","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514083912?lang=en_us&edition=fundamental","pubTime":"2025-02-26 20:00","pubTimestamp":1740571200,"startTime":"0","endTime":"0","summary":"FDA decision expected by July 30, 2025TARRYTOWN, N.Y., Feb.  26, 2025  (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FD","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/26/3032757/0/en/Odronextamab-BLA-Accepted-for-FDA-Review-for-the-Treatment-of-Relapsed-Refractory-Follicular-Lymphoma.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053666078.USD","LU2362541273.HKD","LU0823416689.USD","BK4094","LU0320765992.SGD","LU0889565916.HKD","LU2362540622.SGD","LU0109394709.USD","LU2237438978.USD","LU2089984988.USD","BK4585","LU0058720904.USD","LU1917777945.USD","LU2362541513.USD","LU0114720955.EUR","LU1974910355.USD","LU2023250504.SGD","LU0289739699.SGD","LU2468319806.SGD","LU2106854487.HKD","BK4588","LU0882574055.USD","BK4139","REGN","FL"],"gpt_icon":0},{"id":"2514042012","title":"Regeneron Pharmaceuticals, Inc. (REGN): Among the Stocks That Will Go to The Moon According to Analysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2514042012","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514042012?lang=en_us&edition=fundamental","pubTime":"2025-02-26 01:26","pubTimestamp":1740504371,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 15 Stocks That Will Go to The Moon According to Analysts.In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc.  stands against the other stocks.While stocks initially fell based on worries regarding Trump tariffs on America’s major trading partners, major indexes recovered from their initial losses as the President delayed tariffs on Mexico. He agreed to a 30-day pause on tariffs on Mexico and Canada in return for the two countries bolstering border enforcement to halt fentanyl smuggling and money laundering.Reuters reported that Trump raising tariffs on steel and aluminum imports to a flat 25% pushed up share prices of US steelmakers. The chaos around tariffs doesn’t end here. According to CNN, the President is looking to pursue more tariffs. Trump has been keen on reciprocal tariffs and wants agencies to investigate plans for new reciprocal tariffs that would increase America’s revenue. He reiterated this keenness say","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/regeneron-pharmaceuticals-inc-regn-among-172611976.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","LU2362540622.SGD","LU0114720955.EUR","LU0823416689.USD","LU2237438978.USD","LU0053666078.USD","LU2089984988.USD","LU0109394709.USD","LU2023250504.SGD","LU0882574055.USD","LU2362541513.USD","LU1917777945.USD","LU1974910355.USD","REGN","BK4588","BK4585","LU2468319806.SGD","LU0889565916.HKD","LU0058720904.USD","LU0289739699.SGD","LU2362541273.HKD","LU2106854487.HKD","LU0320765992.SGD"],"gpt_icon":1},{"id":"2514463709","title":"Regeneron Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2514463709","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514463709?lang=en_us&edition=fundamental","pubTime":"2025-02-25 05:42","pubTimestamp":1740433320,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Regeneron Pharmaceuticals Inc.  advanced 1.84% to $713.25 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 0.08% to 43,461.21 and the S&P 500 Index  falling 0.50% to 5,983.25.This was the stock's fifth consecutive day of gains.Regeneron Pharmaceuticals Inc. closed 41.11% short of its 52-week high of $1,211.20, which the company reached on August 27th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Amgen Inc.  rose 2.21% to $309.72, Moderna Inc.  fell 4.59% to $33.90, and Gilead Sciences Inc.  rose 0.98% to $111.03.Trading volume  remained 15,306 below its 50-day average volume of 911,680.Data source: Dow Jones Market Data, FactSet. Data compiled February 24, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN"],"gpt_icon":0},{"id":"2514703399","title":"Regeneron announces updated DB-OTO data from CHORD trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2514703399","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514703399?lang=en_us&edition=fundamental","pubTime":"2025-02-25 04:10","pubTimestamp":1740427854,"startTime":"0","endTime":"0","summary":"Regeneron (REGN) announced updated data for the investigational gene therapy DB-OTO from the Phase 1/2 CHORD trial in 12 children who have profound...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regeneron-announces-updated-db-oto-data-from-chord-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regeneron-announces-updated-db-oto-data-from-chord-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2106854487.HKD","LU0289739699.SGD","REGN","LU2362541513.USD","LU1974910355.USD","BK4139","LU0320765992.SGD","LU0053666078.USD","LU1917777945.USD","LU2089984988.USD","LU2237438978.USD","LU2362540622.SGD","BK4585","BK4588","LU2362541273.HKD","LU0823416689.USD","LU0109394709.USD","LU0058720904.USD","LU0882574055.USD","DB","LU2468319806.SGD","LU0114720955.EUR","BK4566","BK4552","LU0889565916.HKD","LU2023250504.SGD","BK4118"],"gpt_icon":0},{"id":"2514081907","title":"BRIEF-Regeneron's DB-OTO Results Show Hearing Improvements In Children With Profound Genetic Hearing Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2514081907","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514081907?lang=en_us&edition=fundamental","pubTime":"2025-02-25 04:00","pubTimestamp":1740427202,"startTime":"0","endTime":"0","summary":"BRIEF-Regeneron's DB-OTO Results Show Hearing Improvements In Children With Profound Genetic Hearing LossFeb 24  - Regeneron Pharmaceuticals Inc REGN.O:REGENERON: DB-OTO RESULTS SHOW CLINICALLY MEANINGFUL HEARING IMPROVEMENTS IN NEARLY ALL CHILDREN WITH PROFOUND GENETIC HEARING LOSS IN CHORD TRIALREGENERON: 10 OF 11 CHILDREN WITH AT LEAST ONE POST-TREATMENT ASSESSMENT SHOWED NOTABLE IMPROVEMENTS IN HEARING IN PHASE 1/2 CHORD TRIALREGENERON: 72-WEEK RESULTS FOR DB-OTO SHOWS SPEECH AND DEVELOPMENT PROGRESS IN FIRST CHILD DOSED AT 10 MONTHS OF AGESource text: [ID:]Further company coverage: REGN.O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nP8N3LL021:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU2362540622.SGD","LU0320765992.SGD","LU1974910355.USD","LU2362541273.HKD","LU0058720904.USD","LU0823416689.USD","LU2468319806.SGD","LU0109394709.USD","LU2089984988.USD","LU0289739699.SGD","BK4585","LU2362541513.USD","LU0889565916.HKD","LU0882574055.USD","LU2023250504.SGD","LU1917777945.USD","LU2106854487.HKD","LU0053666078.USD","LU2237438978.USD","REGN","BK4588","LU0114720955.EUR"],"gpt_icon":0},{"id":"2514708698","title":"Regeneron's gene therapy study shows improved hearing in children with congenital deafness","url":"https://stock-news.laohu8.com/highlight/detail?id=2514708698","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514708698?lang=en_us&edition=fundamental","pubTime":"2025-02-25 04:00","pubTimestamp":1740427200,"startTime":"0","endTime":"0","summary":"Regeneron's gene therapy study shows improved hearing in children with congenital deafnessBy Puyaan Singh Feb 24 (Reuters) - Regeneron Pharmaceuticals REGN.O said on Monday its experimental gene thera","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nL3N3PF19Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","LU2602419157.SGD","LU1064131342.USD","LU0823416689.USD","LU0320765992.SGD","IE00BFTCPJ56.SGD","LU2491050071.SGD","LU1057294990.SGD","LU2362541273.HKD","LU0058720904.USD","LU2491050154.USD","LU1989771016.USD","SG9999001176.SGD","LU0094547139.USD","SG9999014880.SGD","LU1127390331.HKD","LU0061475181.USD","LU0417517546.SGD","LU1093756325.SGD","REGN","LU0106261372.USD","BK4599","LU1868836757.USD","LU2089984988.USD","SG9999015952.SGD","LU0672654240.SGD","LU0289739699.SGD","SG9999001176.USD","LU0256863811.USD","IE0009355771.USD","BK4585","GB00BDT5M118.USD","LU0006306889.USD","LU1551013342.USD","SGXZ57979304.SGD","LU0820561909.HKD","LU2362541513.USD","LU0238689110.USD","LU1551013425.SGD","LU1868836591.USD","LU2237443895.HKD","LU0708995401.HKD","LU0203202063.USD","SG9999013999.USD","SG9999018857.SGD","LU2461242641.AUD","LU2468319806.SGD","LU0203201768.USD","LU1712237335.SGD"],"gpt_icon":1},{"id":"2514708567","title":"Regeneron: 72-Week Results for Db-Oto Shows Speech and Development Progress in First Child Dosed at 10 Months of Age","url":"https://stock-news.laohu8.com/highlight/detail?id=2514708567","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514708567?lang=en_us&edition=fundamental","pubTime":"2025-02-25 04:00","pubTimestamp":1740427200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nP8N3LL021:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1917777945.USD","LU0289739699.SGD","LU0823416689.USD","LU0053666078.USD","LU0320765992.SGD","LU2089984988.USD","LU2362541273.HKD","LU0058720904.USD","LU2106854487.HKD","REGN","LU0882574055.USD","BK4139","LU2468319806.SGD","LU0109394709.USD","LU2362540622.SGD","LU2237438978.USD","BK4588","LU0114720955.EUR","LU0889565916.HKD","LU2362541513.USD","LU2023250504.SGD","LU1974910355.USD","BK4585"],"gpt_icon":0},{"id":"2514597708","title":"Regeneron: 10 of 11 Children With at Least One Post-Treatment Assessment Showed Notable Improvements in Hearing in Phase 1/2 Chord Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2514597708","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514597708?lang=en_us&edition=fundamental","pubTime":"2025-02-25 04:00","pubTimestamp":1740427200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nP8N3LL021:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2089984988.USD","LU0320765992.SGD","LU0289739699.SGD","LU0823416689.USD","LU1974910355.USD","LU2106854487.HKD","LU0109394709.USD","LU0053666078.USD","LU2362541273.HKD","LU0058720904.USD","LU1917777945.USD","LU0114720955.EUR","BK4588","LU2362540622.SGD","LU0889565916.HKD","LU0882574055.USD","LU2237438978.USD","BK4139","LU2362541513.USD","REGN","BK4585","LU2023250504.SGD","LU2468319806.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/REGN\",params:#limit:5,,,undefined,":[{"date":"2025-04-29","symbol":"REGN","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":7,"defaultRemindTime":1745913600000,"name":null,"time":"Pre-Market","dateTimestamp":1745899200000,"actualEps":null},{"date":"2025-02-20","symbol":"REGN","amount":0.88,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-20","defaultRemindTime":1740061800000,"name":"再生元制药公司","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-20","payableDate":"2025-02-20","currency":"USD","dateTimestamp":1740027600000,"payDate":"2025-03-20"},{"market":"US","date":"2025-02-04","symbol":"REGN","fiscalQuarterEnding":"2024/12","expectedEps":9.62,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1738645200000,"reportTimeType":"pre","actualEps":9.9},{"market":"US","date":"2024-10-31","symbol":"REGN","fiscalQuarterEnding":"2024/09","expectedEps":10.06,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730347200000,"reportTimeType":"pre","actualEps":11.73},{"market":"US","date":"2024-08-01","symbol":"REGN","fiscalQuarterEnding":"2024/06","expectedEps":8.93,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1722484800000,"reportTimeType":"pre","actualEps":10.1}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"REGN\",market:\"US\",,,undefined,":[{"executeDate":"2025-02-20","recordDate":"2025-02-20","paymentDate":"2025-03-20","value":0.88,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"REGN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.4286,"hold":0.25,"sell":0.0357,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4286,"analysts":28,"updateTime":1741924800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/REGN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"REGN","date":"2025-04-16","current":13.531736,"percent":0.264013,"low":7.447139,"twenty":11.205984,"median":17.153272,"eighty":24.444178,"high":30.763504,"avg":17.653562,"sd":6.268051,"marketCap":59710140334},"quantilePoints":[{"date":"2020-04-17","current":29.264276,"twenty":19.849021,"median":60.490119,"eighty":116.648995,"marketCap":61917354902},{"date":"2020-04-24","current":29.801222,"twenty":19.849021,"median":60.209042,"eighty":116.648995,"marketCap":63053425873},{"date":"2020-05-01","current":27.658541,"twenty":19.849021,"median":58.652905,"eighty":116.648995,"marketCap":58519940122},{"date":"2020-05-08","current":27.526215,"twenty":19.849021,"median":57.393234,"eighty":116.585674,"marketCap":62740502883},{"date":"2020-05-15","current":28.176995,"twenty":19.849021,"median":53.421195,"eighty":115.221021,"marketCap":64223824676},{"date":"2020-05-22","current":27.844277,"twenty":19.849021,"median":51.799637,"eighty":114.184286,"marketCap":63465459705},{"date":"2020-05-29","current":27.303609,"twenty":19.849021,"median":51.530268,"eighty":113.633942,"marketCap":62233116768},{"date":"2020-06-05","current":26.599198,"twenty":19.849021,"median":51.349129,"eighty":112.594309,"marketCap":60627552930},{"date":"2020-06-12","current":26.215582,"twenty":19.849021,"median":51.102486,"eighty":112.289501,"marketCap":59753175659},{"date":"2020-06-19","current":28.689708,"twenty":19.849021,"median":50.420041,"eighty":111.71033,"marketCap":65392452064},{"date":"2020-06-26","current":27.239005,"twenty":19.849021,"median":49.850558,"eighty":110.92935,"marketCap":62085863918},{"date":"2020-07-02","current":27.733117,"twenty":19.849021,"median":40.392331,"eighty":110.784746,"marketCap":63212094340},{"date":"2020-07-10","current":27.662275,"twenty":19.849021,"median":31.979399,"eighty":110.206964,"marketCap":63050623973},{"date":"2020-07-17","current":28.695946,"twenty":19.849021,"median":31.36985,"eighty":108.726161,"marketCap":65406669581},{"date":"2020-07-24","current":27.131182,"twenty":19.849021,"median":31.004812,"eighty":106.696094,"marketCap":61840103988},{"date":"2020-07-31","current":28.161734,"twenty":19.849021,"median":30.808341,"eighty":104.408478,"marketCap":64189040838},{"date":"2020-08-07","current":21.875339,"twenty":19.849021,"median":30.656632,"eighty":101.923911,"marketCap":65265075387},{"date":"2020-08-14","current":21.60587,"twenty":19.849021,"median":30.354205,"eighty":101.37008,"marketCap":64461113542},{"date":"2020-08-21","current":21.356152,"twenty":19.849021,"median":30.042238,"eighty":99.974583,"marketCap":63716080837},{"date":"2020-08-28","current":21.254572,"twenty":19.849021,"median":29.867177,"eighty":98.620251,"marketCap":63413016686},{"date":"2020-09-04","current":20.469796,"twenty":19.849021,"median":29.681793,"eighty":97.739726,"marketCap":61071635658},{"date":"2020-09-11","current":19.2138,"twenty":19.673575,"median":29.474412,"eighty":97.336675,"marketCap":57324373708},{"date":"2020-09-18","current":19.583792,"twenty":19.656234,"median":29.203553,"eighty":96.645594,"marketCap":58428242785},{"date":"2020-09-25","current":20.247589,"twenty":19.637789,"median":29.093505,"eighty":95.995591,"marketCap":60408682828},{"date":"2020-10-02","current":19.920981,"twenty":19.637789,"median":28.953278,"eighty":94.856997,"marketCap":59434247398},{"date":"2020-10-09","current":21.235526,"twenty":19.637789,"median":28.860353,"eighty":93.407176,"marketCap":63356192158},{"date":"2020-10-16","current":21.153345,"twenty":19.637789,"median":28.756642,"eighty":89.782622,"marketCap":63111004841},{"date":"2020-10-23","current":20.450397,"twenty":19.637789,"median":28.691316,"eighty":88.348748,"marketCap":61013758824},{"date":"2020-10-30","current":19.171828,"twenty":19.596771,"median":28.536662,"eighty":84.18776,"marketCap":57199149284},{"date":"2020-11-06","current":19.330759,"twenty":19.563112,"median":28.419067,"eighty":80.669454,"marketCap":61007874618},{"date":"2020-11-13","current":18.942826,"twenty":19.391778,"median":28.342989,"eighty":76.671574,"marketCap":59783558673},{"date":"2020-11-20","current":17.347954,"twenty":19.273386,"median":28.194062,"eighty":74.98798,"marketCap":54750142517},{"date":"2020-11-27","current":17.191109,"twenty":19.172764,"median":28.166858,"eighty":74.433116,"marketCap":54255138915},{"date":"2020-12-04","current":16.468751,"twenty":19.105699,"median":28.124531,"eighty":73.576979,"marketCap":51975378191},{"date":"2020-12-11","current":16.0447,"twenty":19.031974,"median":28.045787,"eighty":73.249222,"marketCap":50637074210},{"date":"2020-12-18","current":16.684121,"twenty":18.978847,"median":28.003825,"eighty":72.725467,"marketCap":52655084629},{"date":"2020-12-24","current":16.351033,"twenty":18.951722,"median":27.893932,"eighty":72.508831,"marketCap":51603861628},{"date":"2020-12-31","current":16.156398,"twenty":18.869944,"median":27.783005,"eighty":72.122981,"marketCap":50989592766},{"date":"2021-01-08","current":16.67877,"twenty":18.812345,"median":27.748475,"eighty":71.867927,"marketCap":52638197512},{"date":"2021-01-15","current":17.320865,"twenty":18.741004,"median":27.670408,"eighty":71.690256,"marketCap":54664651490},{"date":"2021-01-22","current":17.984699,"twenty":18.702345,"median":27.64431,"eighty":71.398793,"marketCap":56759709378},{"date":"2021-01-29","current":16.849661,"twenty":18.613885,"median":27.588588,"eighty":71.196483,"marketCap":53177529795},{"date":"2021-02-05","current":14.990488,"twenty":18.469712,"median":27.52903,"eighty":70.956334,"marketCap":52664583632},{"date":"2021-02-12","current":14.395598,"twenty":18.339492,"median":27.404838,"eighty":70.822506,"marketCap":50574613240},{"date":"2021-02-19","current":13.94353,"twenty":18.247865,"median":27.322464,"eighty":70.650351,"marketCap":48986410835},{"date":"2021-02-26","current":13.356584,"twenty":18.183087,"median":27.239458,"eighty":70.34583,"marketCap":46924351319},{"date":"2021-03-05","current":13.682665,"twenty":18.137069,"median":27.131182,"eighty":70.094632,"marketCap":48069939939},{"date":"2021-03-12","current":13.975842,"twenty":18.094122,"median":27.034693,"eighty":69.991059,"marketCap":49099928253},{"date":"2021-03-19","current":14.042244,"twenty":17.992123,"median":26.957419,"eighty":69.774786,"marketCap":49333211754},{"date":"2021-03-26","current":14.1374,"twenty":17.91755,"median":26.838925,"eighty":69.560413,"marketCap":49667515342},{"date":"2021-04-01","current":14.078706,"twenty":17.836459,"median":26.740955,"eighty":69.380807,"marketCap":49461309390},{"date":"2021-04-09","current":14.08582,"twenty":17.582883,"median":26.667813,"eighty":69.047731,"marketCap":49486304051},{"date":"2021-04-16","current":14.898948,"twenty":17.531653,"median":26.603923,"eighty":68.92796,"marketCap":52342985492},{"date":"2021-04-23","current":14.400461,"twenty":17.378502,"median":26.576788,"eighty":68.754213,"marketCap":50591699595},{"date":"2021-04-30","current":14.184148,"twenty":17.314319,"median":26.47571,"eighty":68.667059,"marketCap":49831747330},{"date":"2021-05-07","current":12.848195,"twenty":17.236982,"median":26.416524,"eighty":68.548435,"marketCap":51441604940},{"date":"2021-05-14","current":13.362123,"twenty":17.131868,"median":26.350888,"eighty":68.476599,"marketCap":53499269138},{"date":"2021-05-21","current":13.106065,"twenty":16.947039,"median":26.270161,"eighty":68.395732,"marketCap":52474061510},{"date":"2021-05-28","current":12.995106,"twenty":16.837354,"median":26.029338,"eighty":68.15674,"marketCap":52029804872},{"date":"2021-06-04","current":13.239784,"twenty":16.702149,"median":25.825146,"eighty":68.017841,"marketCap":53009447716},{"date":"2021-06-11","current":13.593093,"twenty":16.634935,"median":25.762014,"eighty":67.890019,"marketCap":54424027129},{"date":"2021-06-18","current":13.913037,"twenty":16.514074,"median":25.58899,"eighty":67.722101,"marketCap":55705018881},{"date":"2021-06-25","current":14.239706,"twenty":16.438175,"median":25.425582,"eighty":67.525077,"marketCap":57012935279},{"date":"2021-07-02","current":15.095563,"twenty":16.378422,"median":25.38134,"eighty":67.387984,"marketCap":60439614106},{"date":"2021-07-09","current":15.011762,"twenty":16.299089,"median":25.245133,"eighty":67.28571,"marketCap":60104091610},{"date":"2021-07-16","current":15.085217,"twenty":16.168829,"median":25.161304,"eighty":66.948314,"marketCap":60398191576},{"date":"2021-07-23","current":15.165656,"twenty":16.140773,"median":25.057563,"eighty":66.699512,"marketCap":60720251750},{"date":"2021-07-30","current":14.862006,"twenty":16.05773,"median":24.844212,"eighty":66.473671,"marketCap":59504500482},{"date":"2021-08-06","current":10.234607,"twenty":15.941934,"median":24.580228,"eighty":66.222266,"marketCap":63509831394},{"date":"2021-08-13","current":10.467996,"twenty":15.811105,"median":24.409963,"eighty":65.572203,"marketCap":64958104241},{"date":"2021-08-20","current":11.112707,"twenty":15.71172,"median":24.133895,"eighty":65.35903,"marketCap":68958789033},{"date":"2021-08-27","current":11.113042,"twenty":15.594292,"median":23.952572,"eighty":64.943681,"marketCap":68960868391},{"date":"2021-09-03","current":11.385804,"twenty":15.416611,"median":23.896291,"eighty":64.163045,"marketCap":70653465803},{"date":"2021-09-10","current":10.898585,"twenty":15.358543,"median":23.822687,"eighty":64.001642,"marketCap":67630079271},{"date":"2021-09-17","current":10.921874,"twenty":15.31188,"median":23.556993,"eighty":63.614678,"marketCap":67774594652},{"date":"2021-09-24","current":10.704401,"twenty":15.216063,"median":23.36376,"eighty":63.039237,"marketCap":66425091310},{"date":"2021-10-01","current":9.563257,"twenty":15.168295,"median":23.248274,"eighty":62.60394,"marketCap":59343837641},{"date":"2021-10-08","current":9.215268,"twenty":15.152615,"median":23.044477,"eighty":62.187301,"marketCap":57184424358},{"date":"2021-10-15","current":9.269217,"twenty":15.096804,"median":22.886718,"eighty":61.909902,"marketCap":57519200996},{"date":"2021-10-22","current":9.589562,"twenty":15.075632,"median":22.781044,"eighty":60.689685,"marketCap":59507067244},{"date":"2021-10-29","current":10.721826,"twenty":15.02843,"median":22.711601,"eighty":58.441572,"marketCap":66533217926},{"date":"2021-11-05","current":9.140146,"twenty":15.010362,"median":22.587367,"eighty":56.983625,"marketCap":63939894320},{"date":"2021-11-12","current":9.433987,"twenty":14.972274,"median":22.403299,"eighty":52.676989,"marketCap":65995456216},{"date":"2021-11-19","current":9.75503,"twenty":14.914028,"median":22.242861,"eighty":51.731325,"marketCap":68241309194},{"date":"2021-11-26","current":9.615582,"twenty":14.873644,"median":22.206358,"eighty":51.46717,"marketCap":67265806015},{"date":"2021-12-03","current":9.493174,"twenty":14.846146,"median":22.027357,"eighty":51.289641,"marketCap":66409496151},{"date":"2021-12-10","current":10.006722,"twenty":14.763396,"median":21.89368,"eighty":50.996878,"marketCap":70002024471},{"date":"2021-12-17","current":9.255829,"twenty":14.645835,"median":21.852902,"eighty":50.192382,"marketCap":64749154191},{"date":"2021-12-23","current":9.347001,"twenty":14.543935,"median":21.806579,"eighty":49.835452,"marketCap":65386942979},{"date":"2021-12-31","current":9.43877,"twenty":14.480705,"median":21.69052,"eighty":32.798336,"marketCap":66028913989},{"date":"2022-01-07","current":9.023417,"twenty":14.400343,"median":21.58144,"eighty":31.955254,"marketCap":63123315560},{"date":"2022-01-14","current":9.195447,"twenty":14.360499,"median":21.468059,"eighty":31.332217,"marketCap":64326749814},{"date":"2022-01-21","current":9.287515,"twenty":14.29746,"median":21.412668,"eighty":31.053495,"marketCap":64970811934},{"date":"2022-01-28","current":9.340125,"twenty":14.271924,"median":21.249665,"eighty":30.821672,"marketCap":65338847431},{"date":"2022-02-04","current":8.06582,"twenty":14.211698,"median":21.155814,"eighty":30.665092,"marketCap":65133918575},{"date":"2022-02-11","current":8.414784,"twenty":14.141195,"median":20.886786,"eighty":30.397746,"marketCap":67951902021},{"date":"2022-02-18","current":8.107934,"twenty":14.100469,"median":20.718789,"eighty":30.063963,"marketCap":65473995536},{"date":"2022-02-25","current":8.154462,"twenty":14.0749,"median":20.630748,"eighty":29.944922,"marketCap":65849726202},{"date":"2022-03-04","current":8.177528,"twenty":14.052898,"median":20.548589,"eighty":29.711783,"marketCap":66035994945},{"date":"2022-03-11","current":8.469748,"twenty":13.990355,"median":20.497058,"eighty":29.510771,"marketCap":68395753827},{"date":"2022-03-18","current":9.041269,"twenty":13.952186,"median":20.431603,"eighty":29.231348,"marketCap":73010961095},{"date":"2022-03-25","current":8.96337,"twenty":13.923409,"median":20.297711,"eighty":29.102336,"marketCap":72381904938},{"date":"2022-04-01","current":9.158447,"twenty":13.87369,"median":20.180575,"eighty":28.966736,"marketCap":73957206312},{"date":"2022-04-08","current":9.738536,"twenty":13.848877,"median":20.056598,"eighty":28.871934,"marketCap":78641599112},{"date":"2022-04-14","current":9.661823,"twenty":13.817339,"median":19.925312,"eighty":28.815517,"marketCap":78022122491},{"date":"2022-04-22","current":9.180836,"twenty":13.785109,"median":19.790673,"eighty":28.696957,"marketCap":74138001167},{"date":"2022-04-29","current":8.794298,"twenty":13.737566,"median":19.660289,"eighty":28.556678,"marketCap":71016593927},{"date":"2022-05-06","current":8.46164,"twenty":13.72215,"median":19.591904,"eighty":28.472288,"marketCap":67131266171},{"date":"2022-05-13","current":8.766805,"twenty":13.695689,"median":19.451906,"eighty":28.362701,"marketCap":69552323150},{"date":"2022-05-20","current":8.97894,"twenty":13.651777,"median":19.315239,"eighty":28.201625,"marketCap":71235318701},{"date":"2022-05-27","current":9.408914,"twenty":13.61647,"median":19.182482,"eighty":28.169777,"marketCap":74646563203},{"date":"2022-06-03","current":8.560781,"twenty":13.580763,"median":19.147609,"eighty":28.138912,"marketCap":67917813387},{"date":"2022-06-10","current":7.76575,"twenty":13.496152,"median":19.040029,"eighty":28.05351,"marketCap":61610351191},{"date":"2022-06-17","current":7.88988,"twenty":13.458929,"median":18.983291,"eighty":28.012848,"marketCap":62595151404},{"date":"2022-06-24","current":8.318225,"twenty":13.394252,"median":18.968689,"eighty":27.917096,"marketCap":65993466363},{"date":"2022-07-01","current":8.086125,"twenty":13.329334,"median":18.871653,"eighty":27.782289,"marketCap":64152083907},{"date":"2022-07-08","current":8.44154,"twenty":13.241565,"median":18.818752,"eighty":27.753004,"marketCap":66971801804},{"date":"2022-07-15","current":8.250999,"twenty":13.112583,"median":18.780003,"eighty":27.691117,"marketCap":65460122702},{"date":"2022-07-22","current":7.959958,"twenty":13.007521,"median":18.702505,"eighty":27.643858,"marketCap":63151121765},{"date":"2022-07-29","current":7.89993,"twenty":12.891389,"median":18.620106,"eighty":27.587706,"marketCap":62674883587},{"date":"2022-08-05","current":11.535488,"twenty":11.550716,"median":18.471047,"eighty":27.528467,"marketCap":65600015462},{"date":"2022-08-12","current":11.819359,"twenty":11.550716,"median":18.341073,"eighty":27.404209,"marketCap":67214331124},{"date":"2022-08-19","current":11.624785,"twenty":11.550716,"median":18.231129,"eighty":27.303428,"marketCap":66107829991},{"date":"2022-08-26","current":11.207815,"twenty":11.371909,"median":18.181433,"eighty":27.225906,"marketCap":63736603409},{"date":"2022-09-02","current":10.915297,"twenty":11.30967,"median":18.134856,"eighty":27.121826,"marketCap":62073109919},{"date":"2022-09-09","current":13.616768,"twenty":11.259308,"median":18.095368,"eighty":27.037827,"marketCap":77435835791},{"date":"2022-09-16","current":13.353201,"twenty":11.259308,"median":17.997073,"eighty":26.966349,"marketCap":75936981116},{"date":"2022-09-23","current":13.109373,"twenty":11.259308,"median":17.919992,"eighty":26.835951,"marketCap":74550380180},{"date":"2022-09-30","current":12.95033,"twenty":11.259308,"median":17.763862,"eighty":26.722775,"marketCap":73645935776},{"date":"2022-10-07","current":13.580109,"twenty":11.259308,"median":17.582147,"eighty":26.649626,"marketCap":77227364563},{"date":"2022-10-14","current":13.837473,"twenty":11.259308,"median":17.514489,"eighty":26.601993,"marketCap":78690939491},{"date":"2022-10-21","current":13.421066,"twenty":11.259308,"median":17.357987,"eighty":26.567778,"marketCap":76322920159},{"date":"2022-10-28","current":14.113824,"twenty":11.259308,"median":17.305502,"eighty":26.472046,"marketCap":80262491824},{"date":"2022-11-04","current":14.720939,"twenty":11.259308,"median":17.230044,"eighty":26.401701,"marketCap":79055860306},{"date":"2022-11-11","current":14.606387,"twenty":11.259308,"median":17.119207,"eighty":26.346411,"marketCap":78440681160},{"date":"2022-11-18","current":14.651731,"twenty":11.259308,"median":16.930926,"eighty":26.239227,"marketCap":78684189572},{"date":"2022-11-25","current":14.641787,"twenty":11.259308,"median":16.849661,"eighty":26.033735,"marketCap":78630788605},{"date":"2022-12-02","current":15.241595,"twenty":11.259308,"median":16.684121,"eighty":25.823128,"marketCap":81851934964},{"date":"2022-12-09","current":14.916831,"twenty":11.259308,"median":16.625596,"eighty":25.738839,"marketCap":80107859366},{"date":"2022-12-16","current":14.382056,"twenty":11.259308,"median":16.468751,"eighty":25.567197,"marketCap":77235955333},{"date":"2022-12-23","current":14.453054,"twenty":11.259308,"median":16.426279,"eighty":25.414911,"marketCap":77617238241},{"date":"2022-12-30","current":14.348645,"twenty":11.259308,"median":16.386349,"eighty":25.384384,"marketCap":77056528083},{"date":"2023-01-06","current":14.660083,"twenty":11.259308,"median":16.317075,"eighty":25.250581,"marketCap":78729046385},{"date":"2023-01-13","current":14.361373,"twenty":11.259308,"median":16.169536,"eighty":25.174538,"marketCap":77124881321},{"date":"2023-01-20","current":14.358788,"twenty":11.259308,"median":16.151382,"eighty":25.098264,"marketCap":77110997070},{"date":"2023-01-27","current":14.773045,"twenty":11.259308,"median":16.092523,"eighty":24.875579,"marketCap":79335681376},{"date":"2023-02-03","current":19.278951,"twenty":11.259308,"median":15.99554,"eighty":24.688912,"marketCap":83639799356},{"date":"2023-02-10","current":18.637362,"twenty":11.259308,"median":15.99554,"eighty":24.479131,"marketCap":80856330298},{"date":"2023-02-17","current":18.419158,"twenty":11.259308,"median":15.99554,"eighty":24.334872,"marketCap":79909674829},{"date":"2023-02-24","current":18.62211,"twenty":11.259308,"median":15.99554,"eighty":24.08253,"marketCap":80790160468},{"date":"2023-03-03","current":19.17094,"twenty":11.259308,"median":15.99554,"eighty":23.912342,"marketCap":83171207087},{"date":"2023-03-10","current":18.376354,"twenty":11.259308,"median":15.99554,"eighty":23.83133,"marketCap":79723972404},{"date":"2023-03-17","current":18.392344,"twenty":11.259308,"median":15.99554,"eighty":23.634714,"marketCap":79793343999},{"date":"2023-03-24","current":20.172169,"twenty":11.259308,"median":15.99554,"eighty":23.395584,"marketCap":87514936240},{"date":"2023-03-31","current":20.213251,"twenty":11.270868,"median":16.006911,"eighty":23.269698,"marketCap":87693167878},{"date":"2023-04-06","current":20.300582,"twenty":11.270868,"median":16.006911,"eighty":23.16464,"marketCap":88072043517},{"date":"2023-04-14","current":20.426781,"twenty":11.259308,"median":15.99554,"eighty":22.981137,"marketCap":88619545496},{"date":"2023-04-21","current":19.633424,"twenty":11.259308,"median":15.99554,"eighty":22.826311,"marketCap":85177647089},{"date":"2023-04-28","current":19.560756,"twenty":11.259308,"median":15.99554,"eighty":22.744778,"marketCap":84862383141},{"date":"2023-05-05","current":19.3053,"twenty":11.259308,"median":15.99554,"eighty":22.693077,"marketCap":80748278285},{"date":"2023-05-12","current":19.092498,"twenty":11.247747,"median":15.988674,"eighty":22.679792,"marketCap":79858192074},{"date":"2023-05-19","current":19.141409,"twenty":11.247747,"median":15.988674,"eighty":22.52179,"marketCap":80062772659},{"date":"2023-05-26","current":18.565743,"twenty":11.247747,"median":15.988674,"eighty":22.52179,"marketCap":77654934150},{"date":"2023-06-02","current":18.723744,"twenty":11.247747,"median":15.988674,"eighty":22.416292,"marketCap":78315804417},{"date":"2023-06-09","current":19.209014,"twenty":11.247747,"median":15.988674,"eighty":22.202364,"marketCap":80345543730},{"date":"2023-06-16","current":20.052795,"twenty":11.247747,"median":15.988674,"eighty":21.930123,"marketCap":83874826599},{"date":"2023-06-23","current":19.969313,"twenty":11.236187,"median":15.981807,"eighty":21.872257,"marketCap":83525647171},{"date":"2023-06-30","current":18.141164,"twenty":11.224626,"median":15.96462,"eighty":21.812599,"marketCap":75879046138},{"date":"2023-07-07","current":18.049231,"twenty":11.224626,"median":15.96462,"eighty":21.69052,"marketCap":75494520326},{"date":"2023-07-14","current":18.462799,"twenty":11.224626,"median":15.96462,"eighty":21.546615,"marketCap":77224350928},{"date":"2023-07-21","current":18.51504,"twenty":11.224626,"median":15.96462,"eighty":21.443977,"marketCap":77442855847},{"date":"2023-07-28","current":19.069195,"twenty":11.224626,"median":15.96462,"eighty":21.26942,"marketCap":79760721743},{"date":"2023-08-04","current":19.014155,"twenty":11.224626,"median":15.96462,"eighty":21.191438,"marketCap":81741853001},{"date":"2023-08-11","current":19.545551,"twenty":11.224626,"median":15.96462,"eighty":20.904333,"marketCap":84026322961},{"date":"2023-08-18","current":19.637239,"twenty":11.224626,"median":15.96462,"eighty":20.742089,"marketCap":84420489392},{"date":"2023-08-25","current":20.487077,"twenty":11.224626,"median":15.96462,"eighty":20.708932,"marketCap":88073945988},{"date":"2023-09-01","current":20.370742,"twenty":11.224626,"median":15.96462,"eighty":20.579258,"marketCap":87573820839},{"date":"2023-09-08","current":20.340426,"twenty":11.224626,"median":15.96462,"eighty":20.556869,"marketCap":87443491616},{"date":"2023-09-15","current":20.515915,"twenty":11.224626,"median":15.96462,"eighty":20.525527,"marketCap":88197917688},{"date":"2023-09-22","current":20.294089,"twenty":11.224626,"median":15.96462,"eighty":20.503675,"marketCap":87244289226},{"date":"2023-09-29","current":20.569892,"twenty":11.224626,"median":15.96462,"eighty":20.497429,"marketCap":88429967281},{"date":"2023-10-06","current":20.484859,"twenty":11.224626,"median":15.96462,"eighty":20.47919,"marketCap":88064409704},{"date":"2023-10-13","current":20.66651,"twenty":11.224626,"median":15.96462,"eighty":20.47919,"marketCap":88845325455},{"date":"2023-10-20","current":19.930788,"twenty":11.224626,"median":15.96462,"eighty":20.469796,"marketCap":85682457723},{"date":"2023-10-27","current":19.520904,"twenty":11.217472,"median":15.933685,"eighty":20.452301,"marketCap":83920364243},{"date":"2023-11-03","current":21.737851,"twenty":11.217472,"median":15.933685,"eighty":20.408361,"marketCap":86757938711},{"date":"2023-11-10","current":21.323755,"twenty":11.217472,"median":15.933685,"eighty":20.408361,"marketCap":85105237415},{"date":"2023-11-17","current":21.224631,"twenty":11.217472,"median":15.933685,"eighty":20.421192,"marketCap":84709626635},{"date":"2023-11-24","current":21.271528,"twenty":11.217472,"median":15.933685,"eighty":20.452301,"marketCap":84896797327},{"date":"2023-12-01","current":21.951269,"twenty":11.217472,"median":15.933685,"eighty":20.452301,"marketCap":87609708889},{"date":"2023-12-08","current":22.627279,"twenty":11.219857,"median":15.940559,"eighty":20.455788,"marketCap":90307731873},{"date":"2023-12-15","current":23.341925,"twenty":11.219857,"median":15.940559,"eighty":20.455788,"marketCap":93159957984},{"date":"2023-12-22","current":22.432763,"twenty":11.217472,"median":15.933685,"eighty":20.452301,"marketCap":89531398889},{"date":"2023-12-29","current":23.493808,"twenty":11.215088,"median":15.919407,"eighty":20.445674,"marketCap":93766135792},{"date":"2024-01-05","current":24.305712,"twenty":11.212703,"median":15.905129,"eighty":20.426781,"marketCap":97006528395},{"date":"2024-01-12","current":24.406967,"twenty":11.212703,"median":15.905129,"eighty":20.426781,"marketCap":97410646934},{"date":"2024-01-19","current":24.780811,"twenty":11.212541,"median":15.891644,"eighty":20.415603,"marketCap":98902695120},{"date":"2024-01-26","current":25.283622,"twenty":11.212703,"median":15.905129,"eighty":20.426781,"marketCap":100909462708},{"date":"2024-02-02","current":25.521038,"twenty":11.212703,"median":15.905129,"eighty":20.426781,"marketCap":101857014335},{"date":"2024-02-09","current":25.724697,"twenty":11.212703,"median":15.905129,"eighty":20.459114,"marketCap":101705162231},{"date":"2024-02-16","current":25.950297,"twenty":11.212703,"median":15.905129,"eighty":20.47919,"marketCap":102597095968},{"date":"2024-02-23","current":26.226454,"twenty":11.212703,"median":15.905129,"eighty":20.497429,"marketCap":103688908831},{"date":"2024-03-01","current":26.259071,"twenty":11.215088,"median":15.919407,"eighty":20.518368,"marketCap":103817863106},{"date":"2024-03-08","current":26.455316,"twenty":11.215088,"median":15.919407,"eighty":20.545637,"marketCap":104593737995},{"date":"2024-03-15","current":26.067447,"twenty":11.215088,"median":15.919407,"eighty":20.571273,"marketCap":103060256739},{"date":"2024-03-22","current":26.311258,"twenty":11.215088,"median":15.919407,"eighty":20.621194,"marketCap":104024189946},{"date":"2024-03-28","current":26.264779,"twenty":11.215088,"median":15.919407,"eighty":20.655603,"marketCap":103840430104},{"date":"2024-04-05","current":25.468926,"twenty":11.212703,"median":15.905129,"eighty":20.723691,"marketCap":100693945789},{"date":"2024-04-12","current":25.015007,"twenty":11.212703,"median":15.905129,"eighty":20.904157,"marketCap":98899332126},{"date":"2024-04-19","current":24.299337,"twenty":11.212703,"median":15.947434,"eighty":21.122307,"marketCap":96069860405},{"date":"2024-04-26","current":24.304801,"twenty":11.215088,"median":16.055559,"eighty":21.212036,"marketCap":96091459812},{"date":"2024-05-03","current":26.22078,"twenty":11.215088,"median":16.138956,"eighty":21.263447,"marketCap":101154526467},{"date":"2024-05-10","current":27.070653,"twenty":11.215088,"median":16.168653,"eighty":21.31672,"marketCap":104433166904},{"date":"2024-05-17","current":27.070094,"twenty":11.215088,"median":16.294592,"eighty":21.377367,"marketCap":104431009193},{"date":"2024-05-24","current":27.42218,"twenty":11.215088,"median":16.403186,"eighty":21.543145,"marketCap":105789287676},{"date":"2024-05-31","current":27.124068,"twenty":11.215088,"median":16.446392,"eighty":21.604318,"marketCap":104639228214},{"date":"2024-06-07","current":27.987644,"twenty":11.215088,"median":16.556015,"eighty":21.765364,"marketCap":107970732547},{"date":"2024-06-14","current":28.708036,"twenty":11.212703,"median":16.641161,"eighty":21.875339,"marketCap":110749863104},{"date":"2024-06-21","current":29.206942,"twenty":11.212541,"median":16.702347,"eighty":21.926914,"marketCap":112674540478},{"date":"2024-06-28","current":29.387879,"twenty":11.212055,"median":16.849661,"eighty":22.012139,"marketCap":113372559682},{"date":"2024-07-05","current":28.639241,"twenty":11.212055,"median":16.930926,"eighty":22.201171,"marketCap":110484464767},{"date":"2024-07-12","current":30.210346,"twenty":11.212055,"median":17.140309,"eighty":22.42349,"marketCap":116545472325},{"date":"2024-07-15","current":30.763504,"twenty":11.212055,"median":17.191109,"eighty":22.533173,"marketCap":118679447575},{"date":"2024-08-02","current":27.30119,"twenty":11.206899,"median":17.301169,"eighty":22.615128,"marketCap":117987551031},{"date":"2024-08-09","current":27.805935,"twenty":11.206899,"median":17.352971,"eighty":22.804619,"marketCap":120168907862},{"date":"2024-08-16","current":29.353886,"twenty":11.206899,"median":17.547174,"eighty":23.185349,"marketCap":126858689969},{"date":"2024-08-23","current":29.661828,"twenty":11.206899,"median":17.668241,"eighty":23.520288,"marketCap":128189522712},{"date":"2024-08-30","current":29.443796,"twenty":11.206899,"median":17.89624,"eighty":23.992786,"marketCap":127247254273},{"date":"2024-09-06","current":28.735255,"twenty":11.206899,"median":18.004331,"eighty":24.127024,"marketCap":124185151686},{"date":"2024-09-13","current":29.082408,"twenty":11.206899,"median":18.146003,"eighty":24.305165,"marketCap":125685441639},{"date":"2024-09-20","current":28.726014,"twenty":11.206899,"median":18.30367,"eighty":24.388542,"marketCap":124145215910},{"date":"2024-09-27","current":25.973018,"twenty":11.206899,"median":18.360535,"eighty":24.456418,"marketCap":112247592778},{"date":"2024-10-04","current":25.339402,"twenty":11.206899,"median":18.388792,"eighty":24.700046,"marketCap":109509293778},{"date":"2024-10-11","current":24.950541,"twenty":11.206899,"median":18.407637,"eighty":24.906035,"marketCap":107828753161},{"date":"2024-10-18","current":24.930811,"twenty":11.206899,"median":18.470866,"eighty":25.028446,"marketCap":107743484883},{"date":"2024-10-25","current":23.199293,"twenty":11.206899,"median":18.52949,"eighty":25.028446,"marketCap":100260383988},{"date":"2024-10-31","current":23.046696,"twenty":11.206899,"median":18.566384,"eighty":25.028446,"marketCap":99600904015},{"date":"2024-11-08","current":19.05799,"twenty":11.206442,"median":18.637362,"eighty":25.035165,"marketCap":88705416518},{"date":"2024-11-15","current":18.087847,"twenty":11.206442,"median":18.657932,"eighty":25.035165,"marketCap":84189883902},{"date":"2024-11-22","current":17.20924,"twenty":11.206442,"median":18.657932,"eighty":25.035165,"marketCap":80100405829},{"date":"2024-11-29","current":17.341458,"twenty":11.206442,"median":18.64179,"eighty":25.035165,"marketCap":80715817946},{"date":"2024-12-06","current":17.750134,"twenty":11.206442,"median":18.605435,"eighty":25.035165,"marketCap":82618000854},{"date":"2024-12-13","current":17.127643,"twenty":11.206442,"median":18.54394,"eighty":25.035165,"marketCap":79720614785},{"date":"2024-12-20","current":16.371315,"twenty":11.206442,"median":18.478932,"eighty":25.035165,"marketCap":76200285330},{"date":"2024-12-27","current":16.566176,"twenty":11.206442,"median":18.419158,"eighty":25.035165,"marketCap":77107265077},{"date":"2025-01-03","current":16.531734,"twenty":11.206442,"median":18.397243,"eighty":25.035165,"marketCap":76946956675},{"date":"2025-01-10","current":16.957053,"twenty":11.205984,"median":18.379244,"eighty":25.041885,"marketCap":78926604046},{"date":"2025-01-17","current":16.024125,"twenty":11.205984,"median":18.326784,"eighty":25.041885,"marketCap":74584290575},{"date":"2025-01-24","current":16.056718,"twenty":11.205984,"median":18.268644,"eighty":25.041885,"marketCap":74735991813},{"date":"2025-01-31","current":15.789506,"twenty":11.205984,"median":18.268644,"eighty":25.041885,"marketCap":73492256835},{"date":"2025-02-07","current":17.513328,"twenty":11.205984,"median":18.205402,"eighty":25.041885,"marketCap":77279312131},{"date":"2025-02-14","current":16.353971,"twenty":11.205984,"median":18.068539,"eighty":25.041885,"marketCap":72163532332},{"date":"2025-02-21","current":16.881503,"twenty":11.205984,"median":17.989927,"eighty":25.041885,"marketCap":74491319165},{"date":"2025-02-28","current":17.045462,"twenty":11.205984,"median":17.861315,"eighty":25.041885,"marketCap":75214806015},{"date":"2025-03-07","current":16.940198,"twenty":11.205526,"median":17.547284,"eighty":24.953276,"marketCap":74750318896},{"date":"2025-03-14","current":16.507743,"twenty":11.205526,"median":17.434844,"eighty":24.953276,"marketCap":72842068816},{"date":"2025-03-21","current":16.071408,"twenty":11.205526,"median":17.347954,"eighty":24.876365,"marketCap":70916694786},{"date":"2025-03-28","current":15.421634,"twenty":11.205526,"median":17.320865,"eighty":24.876365,"marketCap":68049503556},{"date":"2025-04-04","current":14.810668,"twenty":11.205526,"median":17.220578,"eighty":24.757629,"marketCap":65353551816},{"date":"2025-04-11","current":13.252327,"twenty":11.205984,"median":17.191443,"eighty":24.571362,"marketCap":58477215997},{"date":"2025-04-16","current":13.531736,"twenty":11.205984,"median":17.153272,"eighty":24.444178,"marketCap":59710140334}],"updateTime":1744883920621}}}